Estimate a covered specialty fill by applying the remaining deductible to the allowed charge, then calculating coinsurance on the remainder and checking the remaining out-of-pocket limit. A fill can include both deductible and coinsurance when it crosses the deductible threshold. Compare that projection with the pharmacy’s adjudicated Patient Pay Amount and any separately documented assistance. The plan, coverage status and transaction inputs determine which steps apply.
Start by identifying what the estimate measures
The SEHP Caremark member page distinguishes an estimated plan allowance from a member cost estimate. For Plans C, J and N, its public search returns an allowance that must be interpreted using the applicable prescription benefits. It recommends a 30-day search and directs active participants to sign in for estimates based on actual enrollment. That distinction matters: an allowance is an input to a calculation; a displayed member estimate may already include benefit calculations. Applying coinsurance again to the latter could produce the wrong answer.
Caremark describes its Check Drug Cost & Coverage tool as a way to check coverage and cost using medication and dosage information. Neither public guidance establishes that every signed-in display exposes a complete, current deductible ledger. For reconciliation, save the displayed amount, its label, the search date and the inputs used. Record whether the estimate was public or based on an enrolled member’s account. Do not infer a missing component from the size of the total alone.
The practical question is whether the estimate and the pharmacy transaction refer to the same fill. A price for one product, strength, quantity, supply duration and pharmacy cannot resolve a claim for another combination. Likewise, a covered-fill estimate and a rejected claim represent different outcomes. First establish that the claim was accepted under the intended benefit; then compare its dollar components. For the preceding coverage and routing work, see the GLP-1 benefit investigation workflow.
Layer one: use the remaining deductible
The HealthCare.gov deductible glossary explains that a deductible is spending required before the plan begins paying certain covered services. It also notes that some plans have separate prescription deductibles and that certain benefits can be paid before a deductible is met. A deductible-first estimate therefore starts with the benefit that covers this prescription and the amount still unsatisfied, rather than assuming that every drug follows one universal rule.
Plan J combines eligible medical and pharmacy spending. As an illustrative variation on the January example, if $300 had already been applied to its $500 single deductible, only $200 would remain. On the same hypothetical $10,000 specialty fill, the uncapped calculation would be $200 plus 30% of $9,800, or $3,140. That variation assumes the medical spending was actually credited, all modeled member payments count toward the applicable limit, and no assistance applies. A medical invoice for $300 does not establish that $300 reached the deductible.
For a plan with a separate pharmacy deductible, substitute that ledger’s remaining amount. For family coverage, confirm the individual and family accumulation rules before calculating a member’s fill; the single-coverage example below does not establish them. The annual deductible in a benefit description sets the starting threshold, while a dated benefit record supplies the remaining balance. Keeping those two records separate prevents a January assumption from silently carrying into an October estimate.
In this model, the deductible portion is the smaller of the allowed charge and the remaining deductible. If the allowed charge is below that remaining deductible, there is no balance left for percentage coinsurance. If the deductible was already met, this portion is zero. Those two cases explain why “deductible-first” does not mean that every fill contains two separate payments.
Layer two: apply the correct tier percentage
The HealthCare.gov coinsurance glossary illustrates percentage cost sharing on allowed costs after a deductible. Plan J defines its Allowed Charge as the contracted reimbursement rate, including applicable sales tax. Use that plan-defined amount for this model. A manufacturer list price, a public retail quote or a pharmacy acquisition benchmark does not establish the allowed amount for the particular claim. The NADAC reading guide addresses the separate acquisition-cost question.
The Plan J benefit table on printed page 6 uses the following tier labels. In particular, its specialty category is Tier 3. Tier numbers from a different plan or a national survey should not be transferred into this table. The rates describe this plan’s 2026 terms, with the assistance exception discussed below.
| Plan J 2026 tier | Published cost-sharing rule |
|---|---|
| 1 — Generic | Deductible, then 20% coinsurance |
| 2 — Preferred brand | Deductible, then 35% coinsurance |
| 3 — Specialty medications | Deductible, then 30% coinsurance; see PrudentRx terms |
| 4 — Non-preferred brand | Deductible, then 60% coinsurance |
| 5 — Discount tier | 100% of discounted cost; non-covered, excluded from deductible/OOP accumulation |
| 6 — Anticancer oral | Deductible, then 20% coinsurance |
National averages can describe variation without pricing a particular prescription. In its 2025 Employer Health Benefits Survey section on tiers not exclusively for specialty drugs, KFF reports average fourth-tier coinsurance of 31% and an average fourth-tier copayment of $123 among workers in plans with three or more such tiers. These figures exclude tiers used only for specialty drugs; KFF reports those separately. Neither average establishes a member’s rate, and $123 is not a promised specialty copayment.
Layer three: check the remaining out-of-pocket limit
For the Plan J example, the combined maximum is $7,350 single or $14,700 family. Eligible member-paid deductible, coinsurance and copayments count toward it. After the applicable limit is reached, eligible pharmacy claims are reimbursed at 100% of the Allowable Charge for the rest of the calendar year. This protection does not turn a non-covered purchase into a covered benefit. The plan expressly excludes Discount Tier medications, other non-covered drugs and claims processed outside Caremark using discount cards or store discount programs from deductible and out-of-pocket accumulation.
Assistance requires a separate check. Plan J says amounts paid through manufacturer assistance programs, including copay cards and coupons, do not count toward its deductible or out-of-pocket maximum. It also offers no member out-of-pocket cost after the deductible for specialty medications through PrudentRx participation and available assistance; members who elect not to participate face 30% coinsurance. The four-fill model follows the latter path. A zero counter payment through assistance cannot be entered as an equivalent amount of member accumulation.
To estimate the cap’s effect in this simplified model, subtract credited spending to date from the annual maximum. That remaining room limits the combined deductible-plus-coinsurance share on the next covered fill. Record the balance immediately before the fill, rather than after it, so the calculation can be reconstructed. Other eligible claims can change the available room between an estimate and dispensing. The model assumes no such intervening claims.
One plan, four fills: the worked reconciliation
This is an authored arithmetic illustration using published plan terms. It is not a claim extract, a live personalized portal result or a forecast of any drug’s price. The assumptions are deliberately fixed so that the transitions between deductible, coinsurance and the annual cap can be inspected.
Period and coverage: January through April 2026, Kansas SEHP Plan J, single coverage. The January fill starts with no prior medical or pharmacy claims, a $500 remaining deductible and $0 credited out-of-pocket spending.
Prescription and routing: one covered specialty fill each month through the required CVS Caremark Specialty Pharmacy, with any required authorization and other coverage conditions satisfied.
Cost input: a hypothetical $10,000 allowed charge for each fill, interpreted using the plan’s definition. Product, quantity and supply duration are held constant; no real drug or market price is implied.
Payment assumptions: no PrudentRx participation, manufacturer assistance, other payer, cash-price adjustment or intervening medical claim. All modeled member payments count toward the combined limit. The benefit year does not reset between these four fills.
| Fill in 2026 | Allowed charge | Deductible share | Coinsurance after cap | Modeled member share | Modeled plan share | Cumulative credited OOP |
|---|---|---|---|---|---|---|
| January | $10,000 | $500 | $2,850 | $3,350 | $6,650 | $3,350 |
| February | $10,000 | $0 | $3,000 | $3,000 | $7,000 | $6,350 |
| March | $10,000 | $0 | $1,000 | $1,000 | $9,000 | $7,350 |
| April | $10,000 | $0 | $0 | $0 | $10,000 | $7,350 |
January crosses the deductible. Subtracting $500 from the $10,000 allowed charge leaves $9,500. Thirty percent of that remainder is $2,850, so the modeled member share is $500 + $2,850 = $3,350. The modeled plan share is $10,000 − $3,350 = $6,650. The deductible is now satisfied, and the remaining out-of-pocket room is $7,350 − $3,350 = $4,000.
February has no deductible portion. Thirty percent of $10,000 is $3,000, below the $4,000 remaining room. Adding that payment to January’s $3,350 produces $6,350 of credited spending. March would otherwise generate another $3,000, but only $7,350 − $6,350 = $1,000 remains before the maximum. The cap limits March’s modeled member share to $1,000. April’s eligible fill has zero modeled member cost because the limit has been reached.
Two consistency checks make the table useful for reviewing an estimate. First, member share plus plan share equals the allowed charge on each row. Second, the increase in cumulative credited spending equals that row’s member share under the stated no-assistance assumptions. The cap is applied to the total member share, including any deductible portion. These checks catch an omitted deductible or an over-cap estimate without claiming to reproduce the PBM’s full adjudication system.
Compare the claim, receipt and benefit statement
The 2026 Caremark Provider Manual section 3.03 requires network providers to disclose Patient Pay before dispensing and collect the adjudicated amount, subject to its stated exceptions. It restricts additional collections for covered pharmacy services. If Caremark determines there was an excess collection, the provider must reimburse it upon Caremark’s request. Sections 3.03.02 and 4.05 require accurate usual-and-customary price reporting and disclosure. These are network-provider requirements, not a guarantee that an estimate becomes an unchangeable legal liability. Coupons, coordination of benefits and permitted waivers have separate conditions.
Keep the claim-assigned amount distinct from cash paid by the member and any amount paid on the member’s behalf. In the no-assistance table those amounts coincide by assumption. In an actual assisted fill, they may differ. A receipt documents a payment; a benefit statement documents the plan’s treatment of a claim. Neither should be treated as proof of the other without matching the prescription, fill date and transaction.
CMS’s guide to reading an explanation of benefits uses medical-visit examples. It explains provider charges, allowed charges, insurer payment and patient balance, and says an EOB is not a bill. The table below is an analytical crosswalk to pharmacy records, not a mandated PBM display format. A pharmacy statement may use different labels or omit deductible and coinsurance components. Request those components when the total alone cannot explain the difference.
| CMS EOB concept | What to seek for the pharmacy fill | Interpretation limit |
|---|---|---|
| Provider charges | Submitted charge and the product/quantity billed | Does not by itself establish the allowed amount or member share. |
| Allowed charges | Amount allowed for the covered prescription | Use the applicable plan definition; do not assume the submitted charge equals it. |
| Paid by insurer | Plan-attributed payment for the matching claim | Do not equate this with a pharmacy’s net remittance after other adjustments. |
| What you owe / patient balance | Patient Pay, any available deductible/coinsurance split, and payment records | Separate assigned cost sharing, assistance and amounts already paid. |
CMS notes that an EOB’s patient balance can include amounts already paid and that a bill should not exceed that balance. Use a discrepancy to request a matched explanation, rather than treating the EOB as a second invoice or a universal pharmacy billing rule. For example, if the table’s January member share had already been collected, a statement displaying $3,350 would not establish another $3,350 still due. Check the payment history and any corrected transaction before calculating an outstanding balance.
Seven checkpoints for an estimate that differs from the claim
These are questions for a reconciliation record, not measured causes ranked by frequency or a complete list of every claim edit. Start with the estimate and accepted claim for the same fill. Where an input is unavailable, leave it unresolved until the pharmacy or plan supplies it; do not invent a balancing adjustment.
Product, quantity and days supply. Compare the medication, strength, quantity and supply duration used in the tool with the actual fill. SEHP recommends a 30-day search; Caremark’s tool asks for medication and dosage information. A difference means the estimates are not directly comparable. Do not assume that doubling quantity doubles the final charge or member share.
Plan year, tier and list effective date. Use the benefit description and drug-list version that apply to the fill date. Plan J says its preferred and specialty lists can change. SEHP posts dated lists, but that does not prove a particular drug moved tiers. Document the actual classification rather than inventing a quarterly change scenario.
Remaining balances and assistance. Compare the pre-fill deductible and credited out-of-pocket amounts with the balances assumed in the estimate. Record PrudentRx participation and any assistance separately. The table’s cap timing changes if assistance reduces cash payment without providing accumulation credit, or other eligible claims use part of the remaining room.
Authorization and coverage conditions. Confirm any required prior authorization applies to the product being dispensed. Plan J requires preapproval for certain drugs and retains coverage discretion. A rejected claim needs a coverage explanation before coinsurance can be reconciled. An authorization alone does not supply an allowed amount or guarantee the member payment.
Dispensing pharmacy. Plan J requires its designated CVS Caremark Specialty Pharmacy for eligible specialty products. Match the estimate’s pharmacy with the dispensing record. Do not model a different provider as merely having a higher coinsurance rate when the plan may not cover that specialty dispensing.
Allowed-charge basis. Plan J includes applicable sales tax in its definition. Confirm whether the estimate and the claim use the same amount and what that amount includes. The document does not establish a tax charge for every prescription or provide a jurisdiction-specific tax calculation. Do not add a guessed tax or fee to close the gap.
Usual-and-customary reporting and later payments. The provider manual requires accurate U&C information and disclosure even when it is below Patient Pay. Ask how a lower cash amount, coupon or other payer was handled for this transaction. These reporting and disclosure provisions do not establish a universal automatic lower-price rule for every plan. Preserve both the adjudication and payment records rather than substituting a public cash quote.
A useful resolution identifies the changed input, the applicable benefit rule and the resulting dollar difference. For example, a confirmed reduction in remaining deductible from $500 to $200 explains the $210 change from the January model’s $3,350 to the illustrative $3,140 calculation, assuming the cap does not bind. An unexplained $210 difference does not prove that medical claims caused it. Record the evidence behind the adjustment and check that the reconstructed total matches the accepted claim.
Boundaries: flat copays, assistance and Medicare
A flat-copay plan requires its own stated dollar terms, deductible rules and annual limit. The KFF average cannot replace those terms. Coinsurance plans can also have per-prescription minimums or maximums, which KFF discusses separately. Before using the simple percentage model, check whether the actual benefit has such a provision. The transferable method is to identify the applicable rule and reconcile the inputs; the specific Plan J rate is not transferable.
For an assisted fill, use the current program terms and the plan’s treatment of assistance. This article does not assign a typical annual assistance cap or a universal reset date. The copay assistance annual-maximum analysis addresses exhaustion and benefit periods; the copay accumulator appeal workflow covers disputes about accumulation. Those are separate decisions from reconciling an accepted fill. Plan J’s published assistance exclusion is the specific rule used here.
Medicare Part D has a different benefit structure. The CMS final CY 2026 redesign fact sheet sets a $615 deductible and 25% initial-coverage coinsurance for the defined standard benefit, with a $2,100 annual out-of-pocket threshold and no enrollee cost sharing for covered Part D drugs in the catastrophic phase. Zero enrollee payment does not mean the plan alone funds the entire claim; the fact sheet assigns liability among plans, manufacturers and CMS. Do not substitute Plan J’s rates, combined medical ledger or assistance assumptions into a Part D estimate.
For those separate Medicare questions, see the Part D redesign explanation. Use the CMS source above for the governing 2026 parameters. For any later benefit year, rebuild the estimate from that year’s terms. A saved 2026 calculation remains evidence of its assumptions, not a quote for a future fill.
Sources
Plan J Prescription Drug Benefit Description, State of Kansas Employees Health Plan (effective January 1, 2026). See printed pages 2, 5–7 and 10–12 for definitions, tiers, accumulation exclusions and PrudentRx.
Prescription - CVS Caremark (State Employee Health Plan). Public estimate and signed-in enrollment guidance.
Get your prescriptions your way (prescription costs & coverage). Tool description; no personalized estimate was executed for this illustration.
2026 Caremark Provider Manual (Section 3.03 Patient Pay; claims submission). Sections 3.03 and 4.05; provider-network scope and stated exceptions apply.
How to read a health insurance explanation of benefits. Medical EOB guidance used for a conceptual pharmacy crosswalk.
Coinsurance (HealthCare.gov glossary). Educational definition and allowed-cost arithmetic.
Deductible (HealthCare.gov glossary). Educational definition, separate deductibles and benefit exceptions.
2025 Employer Health Benefits Survey. Section 9; fourth-tier figures exclude tiers exclusively for specialty drugs.
Final CY 2026 Part D Redesign Program Instructions (fact sheet). Defined standard 2026 benefit and catastrophic-phase liability.
